TherapeuticsMD, Inc. company info

CIK 25743
IRS Number 870233535
State of incorporation NV
Business address 951 YAMATO ROAD, SUITE 220
None
BOCA RATON
FL
33431
Mail address 951 YAMATO ROAD, SUITE 220
None
BOCA RATON
FL
33431

Short summary

TherapeuticsMD, Inc. is a Florida company, with head office located at 951 Yamato Road, Suite 220 Boca Raton, Florida 33431. In 2018 the company owned a total of 181.89 million USD worth of assets, including 152.63 million USD worth of current assets and 28.59 million USD worth of non-current assets. The company amassed the most assets last year, totalling up to 181.89 million USD.

TherapeuticsMD, Inc. Income Statement

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Revenue, Net 1.242.093.828.7815.0320.1419.3616.78
Cost of Goods and Services Sold 4.192.642.74
Gross Profit 0.691.142.476.8211.3515.6415.1714.1413.36
Selling, General and Administrative Expense 3.466.4114.0719.0122.1228.7251.3557.70115.99
Research and development 0.070.114.4913.5543.2272.0453.9433.8527.30
Operating Expenses 3.556.5718.6232.6265.40100.83105.4291.77143.58
Operating Income (Loss) -2.87-5.43-16.15-25.81-54.04-85.19-90.25-77.63-130.22
Interest expense 0.061.911.911.17
Income Tax Expense (Benefit)
Net income -2.87-12.91-35.12-28.42-54.22-85.08-89.88-76.93-132.62

TherapeuticsMD, Inc. Balance Sheet

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Cash and cash equivalents 0.120.081.330.15
Accounts Receivable, Net, Current 0.010.410.962.163.314.483.405.6314.94
Inventories 0.620.821.511.451.250.881.411.884.96
Property, Plant and Equipment, Gross 0.120.060.150.190.200.620.780.851.29
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.03-0.110.070.110.140.170.300.450.62
Goodwill 0.29
Intangible Assets, Net (Excluding Goodwill) 0.240.871.291.982.743.494.46
Other Assets, Noncurrent 1.221.05
Total assets 0.014.8843.0744.4375.68176.59106.88171.90181.89
Current assets 0.013.4540.5141.8572.96174.03103.52167.10152.63
Non-current assets 0.041.322.482.502.652.112.884.4028.59
Accounts payable 0.000.692.052.335.823.048.1111.4325.37
Total current liabilities 0.362.494.606.9511.719.3413.2921.2144.97
Long-term Debt, Excluding Current Maturities 73.1473.50
Total liabilities 0.365.584.606.9512.679.3412.4794.35121.20
Common Stock, Value, Issued 0.020.100.130.150.170.200.200.220.24
Retained Earnings (Accumulated Deficit) -2.03-42.13-64.50-100.62-182.87-261.85-350.57-444.28-558.78

TherapeuticsMD, Inc. Cash Flow

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Net income -2.87-12.91-35.12-28.42-54.22-85.08-89.88-76.93-132.62
Depreciation and amortization 0.020.050.060.060.050.060.130.210.29
Depreciation 0.020.030.030.050.030.030.080.140.18
Amortization of Intangible Assets 0.030.030.010.020.030.050.070.11
Depreciation and amortization 0.020.05
Accounts receivable 0.01-0.020.731.070.460.923.98-0.176.95
Inventories 0.450.031.03-0.570.14-0.490.390.411.78
Accounts payable 0.100.191.330.474.21-3.204.23-3.2618.65
Deferred revenue 1.140.46-1.08-0.52
Net Cash Provided by (Used in) Operating Activities -2.84-4.97-12.74-20.77-45.52-79.04-69.14-76.16-106.81
Payments to Acquire Property, Plant, and Equipment 0.030.030.070.040.030.170.400.060.22
Payments to Acquire Intangible Assets 0.010.210.440.590.420.850.771.11
Net Cash Provided by (Used in) Investing Activities -0.03-0.04-0.27-0.58-0.61-0.58-1.26-0.83-21.50
Proceeds from Issuance of Long-term Debt 75
Proceeds from Issuance of Common Stock 17.9078.6542.7791.37134.8668.5789.91
Net Cash Provided by (Used in) Financing Activities 3.174.7114.4473.9943.3092.97137.2372.58162.79